Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ZYXI Zynex Inc
- Stocks
- Healthcare
- NASDAQ: ZYXI
Price (delayed)
$2.27
Market cap
$68.64M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.24
Enterprise value
$117.42M
Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the company's proprietary NeuroMove device designed to help recovery
Highlights
The debt has contracted by 3.2% YoY
Zynex's net income has plunged by 191% YoY
The equity has declined by 42% since the previous quarter and by 37% year-on-year
Key stats
What are the main financial stats of ZYXI
Market
Valuations
Earnings
Shares outstanding
30.24M
Market cap
$68.64M
Enterprise value
$117.42M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.49
Price to sales (P/S)
0.42
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.68
Revenue
$172.4M
Gross profit
$133.9M
Operating income
-$7.63M
Net income
-$7.41M
EBIT
-$7.61M
EBITDA
-$3.98M
Free cash flow
-$443,000
Per share
Balance sheet
Liquidity
EPS
-$0.24
EPS diluted
-$0.24
Free cash flow per share
-$0.01
Book value per share
$0.65
Revenue per share
$5.46
TBVPS
$2.48
Total assets
$105.76M
Total liabilities
$84.99M
Debt
$73.04M
Equity
$20.77M
Working capital
$40.1M
Debt to equity
3.52
Current ratio
3.46
Quick ratio
2.35
Net debt/EBITDA
-12.27
Margins
Efficiency
Dividend
EBITDA margin
-2.3%
Gross margin
77.7%
Net margin
-4.3%
Operating margin
-4.4%
Return on assets
-6.2%
Return on equity
-23.7%
Return on invested capital
-6.7%
Return on capital employed
-8.5%
Return on sales
-4.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ZYXI stock price
How has the Zynex stock price performed over time
Intraday
-0.44%
1 week
-5.02%
1 month
-4.22%
1 year
-77.3%
YTD
-71.66%
QTD
-12.02%
Financial performance
How have Zynex's revenue and profit performed over time
Revenue
$172.4M
Gross profit
$133.9M
Operating income
-$7.63M
Net income
-$7.41M
Gross margin
77.7%
Net margin
-4.3%
The net margin has plunged by 200% YoY
Zynex's net income has plunged by 191% YoY
Zynex's operating margin has shrunk by 176% YoY
The company's operating income has shrunk by 169% YoY
Price vs fundamentals
How does ZYXI's price correlate with its fundamentals
Growth
What is Zynex's growth rate over time
Valuation
What is Zynex stock price valuation
P/E
N/A
P/B
3.49
P/S
0.42
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.68
The P/B is 51% less than the 5-year quarterly average of 7.1 and 48% less than the last 4 quarters average of 6.7
The equity has declined by 42% since the previous quarter and by 37% year-on-year
The price to sales (P/S) is 86% lower than the 5-year quarterly average of 3.0 and 65% lower than the last 4 quarters average of 1.2
Zynex's revenue has decreased by 10% from the previous quarter and by 9% YoY
Efficiency
How efficient is Zynex business performance
The ROS has plunged by 167% YoY
The ROIC has plunged by 166% YoY
Dividends
What is ZYXI's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did Zynex financials performed over time
The total assets is 24% more than the total liabilities
ZYXI's quick ratio is down by 32% QoQ and by 13% YoY
ZYXI's current ratio is down by 22% from the previous quarter and by 3.4% YoY
Zynex's debt to equity has soared by 70% from the previous quarter and by 54% YoY
The equity has declined by 42% since the previous quarter and by 37% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.